A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Trial details
- Registry ID
- NCT05549505
- Drugs studied
- ARV-471, Anastrozole, Surgical resection of breast tumor
TrialRedline tracks 3 clinical trials sponsored by Arvinas Inc.: 1 Phase 2, 2 Phase 1 / 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryNCT05549505 | ARV-471, Anastrozole, Surgical resection of breast tumor | Completed | 2024-07-13Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsNCT07749586 | ARV-6723, Pembrolizumab, SOC | Recruiting | 2031-03-31Estimated |
| A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationNCT07023731 | ARV-806 | Completed | 2026-10-30Actual |
Names as written in the registry records.